Looking forward to my post-op appointment on Tuesday at Magee and I don't often say I'm looking forward to going there. lol
I am omitting names but am sure someone can find them if they want to.
Just a little background on Magee. Hoping my doctor will be able to make some comments on the technology they are using from Predictive Oncology.
The stock price sure isn't reflecting well but then again, the whole market is heavily manipulated right now.
My doctor is Director, Division of Gynecologic Oncology and
Assistant Professor.
My doctor that did my original surgery in 1997 is,
Chair of Ob/Gyn/RS at Magee-Womens Hospital of UPMC,. he is coleader of Womens Hospital of UPMC Gynecologic Cancer Program, and a professor of medicine in the Department of Obstetrics, Gynecology, and Reproductive Sciences at the University of Pittsburgh School of Medicine. He specializes in all aspects of gynecologic oncology, and has a particular interest in intraperitoneal chemotherapy. and immunotherapty.
He is board-certified in obstetrics and gynecology, as well as gynecologic oncology. He received an undergraduate degree at Gettysburg College in Gettysburg, Pa., and received a medical degree at the University of Pittsburgh School of Medicine. He has completed a residency in obstetrics and gynecology at Magee-Womens Hospital of UPMC, and a fellowship in gynecologic oncology at the University of Alabama at Birmingham.
He is a member of professional organizations including the University of Pittsburgh Physicians Board of Directors, American Medical Association, American College of Surgeons, American College of Obstetricians and Gynecologists, American Association for Cancer Research, American Society of Clinical Oncology, Society of Gynecologic Oncologists, American Society of Colposcopy and Cervical Pathology, International Society for Biological Therapy of Cancer, American Association for the Advancement of Science, and the International Gynecologic Cancer Society.
Let's hope things perk up for this stock. GLTA
